Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIANT: Ginkgolide with Alteplase in Acute Ischemic Stroke
NCT03772847Phase 4Completed
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jul 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Ginkgolide in ischemic stroke (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Modified Rankin Scale Score < 2 at 90 days. Started Jul 2018; status: completed.
02
Drugs
Ginkgolide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03772847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03772847.